VIRTUAL CONTINUING MEDICAL EDUCATION ENDURING PROGRAMS FOR HEALTHCARE PROFESSIONALS

Virtual CME Accredited Programs You Can Take Any Place, Any Time for Free

MAKING THE CONNECTION: Between Patients and Providers, An Integrative Approach to the Treatment of Type 1 and Type 2 Diabetes


PROGRAM TOPICS:

•  Diabetes Distress: What It Is, Why It Is Important, and What To Do About It

•  Focus on Time in Range and Modern Management of Type 1 Diabetes

•  Effective Use of Oral Medications for Type 2 Diabetes: Lowering Cardio-renal Risk While Improving Glycemic Control

•  Injectable Agents and Cardiovascular Effects

•  (*Non-accredited) Communicating Effectively at the Time of the T2D Diagnosis: What Our Patients Can Teach Us

MAKING THE CONNECTION: Between Patients and Providers, Deep Dive Series


PROGRAM TOPICS:

•  Preventing, Halting, and Reversing Type 1 Diabetes: Update in T1D research and potential novel therapies

•  Efficient and Comprehensive type 2 diabetes management: glucose, renal, and cardiovascular health

•  Rapid Fire CGM Interpretation For Efficient And Effective Patient Care

ADVANCES IN ASSESSING & TREATING SEVERE HYPOGLYCEMIA IN PRACTICE: Severe Hypoglycemia is Still a Serious & Significant Problem in Both Type 1 & Type 2 Diabetes


After Completing this Activity, Participants Should be Able to:

•  Describe the clinical, emotional and public health significance of Severe Hypoglycemia in persons with T1D and T2D treated with sulfonylureas and or insulin.

•  Assess patients at risk for Severe Hypoglycemia and discuss recognition and treatment strategies that address individual treatment barriers.

•  Implement a care and education plan for providers to educate their patients about Severe Hypoglycemia using a glucagon option appropriate for them and to ensure each patient has an unexpired glucagon kit at home

UPDATE ON INHALED AND RAPID ACTING INSULINS: New Clinical Trial Data, What Patients Can Benefit, and How to Maximize Success


After Completing this Activity, Participants Should be Able to:

•  Describe the unmet need ultra-rapid insulins address in the management of type 1 and type 2 diabetes

•  Understand clinical trial data for the safety and efficacy of inhaled insulin

•  Identify patients that could benefit from inhaled insulin

•  Describe how to initiate and titrate inhaled insulin in patients with both type 1 and type 2 diabetes